首页> Ophthalmology science> Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial.

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mark R,Barakat

第一单位： Retina Macula Institute of Arizona, Scottsdale, Arizona.

作者： Mark R,Barakat ^[1] ; David,Brown ^[2] ; Allen,Hu ^[3] ; Rahul N,Khurana ^[4] ; Dennis,Marcus ^[5] ; Joel,Pearlman ^[6] ; Charles C,Wykoff ^[2] ; Barry,Kapik ^[7] ; Thomas,Ciulla ^[8]

作者单位： Retina Macula Institute of Arizona, Scottsdale, Arizona. ^[1] Retina Consultants of Texas, Houston, Texas. ^[2] Cumberland Valley Retina Consultants, Hagerstown, Maryland. ^[3] Northern California Retina Vitreous Associates, Mountain View, California. ^[4] Southeast Retina Center, PC, Augusta, Georgia. ^[5] Retina Consultants Medical Group, Sacramento, California. ^[6] Clearside Biomedical, Inc., Alpharetta, Georgia. ^[7] Clearside Biomedical, Inc., Alpharetta, Georgia.;Midwest Eye Institute, Indianapolis, Indiana. ^[8]

DOI 10.1016/j.xops.2024.100586

PMID 39328827

发布时间 2024-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Ophthalmology science

100586页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Ophthalmology science

100586页

检索历史清除

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial.

Ophthalmology science

相似文献

同项目论文

Ophthalmology science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial.

Ophthalmology science

相似文献

同项目论文

Ophthalmology science

相关期刊

检索历史清除